Navigation Links
Colorado Institute for Drug, Device and Diagnostic Development Awards Funding to Fort Collins-based VetDC
Date:6/22/2011

AURORA, Colo., June 22, 2011 /PRNewswire/ -- The Colorado Institute for Drug, Device and Diagnostic Development (CID4), a 501(c)(3) not-for-profit entity focused on advancing the Colorado life science ecosystem through company creation and job growth, has selected Ft. Collins, Colorado-based Veterinary Emerging Technologies Development Corporation (VetDC) to receive funding and management assistance. VetDC in-licenses, develops and commercializes technologies to address serious unmet medical needs in companion animals.

The announcement is made by Kevin M. Smith, CID4 President & CEO, who says, "CID4 is providing funding, as well as access to CID4's expert management team's experience and deep network of potential partners, to VetDC."

In the first quarter of 2011, VetDC completed the acquisition of all North American veterinary rights to VDC-1101 (GS-9219) from Gilead Sciences, allowing for development and commercialization in animal cancer. VDC-1101 is an anti-proliferative agent that preferentially targets lymphoid cells and works by inhibiting DNA synthesis, leading to the induction of apoptosis or programmed cell death.

"We are excited to partner with VetDC and their experienced management team," said Richard C. Duke, Founder and Chief Scientific Officer of CID4. "Our capital and management resources will assist with late-stage clinical trials and the potential commercialization of what may be an important new therapeutic option for animals suffering from lymphoma."

"We are extremely pleased to enter into this financing agreement with CID4," said Steven Roy, President and Chief Executive Officer of VetDC. "The CID4 funding will not only help us advance our lead cancer program, but will also help increase employment."

About VetDC

VetDC, Inc., a Colorado State University start-up headquartered in Fort Collins, Colorado, is a product development company focused on in-licensing, developing and commercializing
'/>"/>

SOURCE The Colorado Institute for Drug, Device and Diagnostic Development
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NIH Funds $1M Research at Quest Product Development and University of Colorado for New Digitally-Controlled Endoscopes
2. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
3. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
4. Dr. Lawrence Spivack, a LASIK Eye Surgeon Expert Serving Denver, Colorado, Joins Elite Circle of Surgeons Listed at Trusted LASIK Surgeons
5. Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009
6. Childrens Hospital in Colorado Rounds off List of 24 Cord Blood Transplant Centers Worldwide Enrolling for ExCell Trial Studying StemEx(R) for Leukemia and Lymphoma
7. Colorado Center for Reproductive Medicine Improves Pregnancy and Implantation Rates Using Comprehensive Chromosomal Screening of IVF Embryos
8. Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret
9. Colorado State University student awarded top student prize in laser research
10. AlloSource Named One of Colorados Top Three Healthcare Companies
11. Regenicin COO Receives Citizenship Award from VFW Post 1 in Colorado
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 15, 2014 Zymo Research Corp., has announced ... for safe ambient temperature storage and transport of ... infectivity of agents in such samples is completely ... of the viral nucleic acids for subsequent analyses.  ... epidemic in West Africa ...
(Date:9/15/2014)... , Sept. 15, 2014 Research and ... Exome Sequencing Market by Product, by Services, by Technology, by ... offering. Whole Exome Sequencing (WES) is next-generation ... genome, i.e. the exon. The exome, which is the total ... the total genome and is actually converted into proteins after ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Applied ... implantable silicones for the medical device and critical ... gel for the implantable medical device market. ... crosslink technology delivering a silicone gel with improved ... Dual Matrix technology consists of two crosslinked networks ...
(Date:9/15/2014)... Maryland , 15 septembre 2014 ... Awareness Week (IPAW) (semaine internationale sur la ... 18 octobre. Initiative conjointe de la Plasma ... sociétés membres , l,IPAW vise à : ... au sujet de la collecte du plasma-aphérèse ...
Breaking Biology Technology:Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids 2Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids 3Global Whole Exome Sequencing (Systems, Kits, Library Preparation, Target Enrichment) Market by Product, by Services, by Technology, by Application - Forecast to 2018 2Global Whole Exome Sequencing (Systems, Kits, Library Preparation, Target Enrichment) Market by Product, by Services, by Technology, by Application - Forecast to 2018 3Applied Silicone Launches Silicone Gel System with Dual Matrix Technology 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3
... be difficult for patients to do, and because of blinking ... the dose is actually absorbed by the eye. Now, researchers ... for Biomaterials and Drug Delivery at Children,s Hospital Boston, have ... amount of medication to the eye, at adjustable rates. They ...
... NEW YORK, July 21 /PRNewswire-Asia-FirstCall/ ... ), ("the Company" or "AOBO"), a pharmaceutical,company dedicated ... of a broad range of prescription and over ... AOBO was honorably elected as one of,the "Top ...
... , , KENILWORTH, N.J., ... financial results for the 2009 second quarter. , ... people have given us the strength to again power through tough challenges ... quarter," said Fred Hassan, chairman and CEO. , ...
Cached Biology Technology:A drug-dispensing contact lens 2American Oriental Bioengineering Honorably Elected a Top 20 Most Competitive Public Pharmaceutical Company in China 2Schering-Plough Reports Financial Results for 2009 Second Quarter 2Schering-Plough Reports Financial Results for 2009 Second Quarter 3Schering-Plough Reports Financial Results for 2009 Second Quarter 4Schering-Plough Reports Financial Results for 2009 Second Quarter 5Schering-Plough Reports Financial Results for 2009 Second Quarter 6Schering-Plough Reports Financial Results for 2009 Second Quarter 7Schering-Plough Reports Financial Results for 2009 Second Quarter 8Schering-Plough Reports Financial Results for 2009 Second Quarter 9Schering-Plough Reports Financial Results for 2009 Second Quarter 10Schering-Plough Reports Financial Results for 2009 Second Quarter 11Schering-Plough Reports Financial Results for 2009 Second Quarter 12Schering-Plough Reports Financial Results for 2009 Second Quarter 13Schering-Plough Reports Financial Results for 2009 Second Quarter 14Schering-Plough Reports Financial Results for 2009 Second Quarter 15Schering-Plough Reports Financial Results for 2009 Second Quarter 16Schering-Plough Reports Financial Results for 2009 Second Quarter 17Schering-Plough Reports Financial Results for 2009 Second Quarter 18Schering-Plough Reports Financial Results for 2009 Second Quarter 19Schering-Plough Reports Financial Results for 2009 Second Quarter 20Schering-Plough Reports Financial Results for 2009 Second Quarter 21Schering-Plough Reports Financial Results for 2009 Second Quarter 22Schering-Plough Reports Financial Results for 2009 Second Quarter 23Schering-Plough Reports Financial Results for 2009 Second Quarter 24Schering-Plough Reports Financial Results for 2009 Second Quarter 25Schering-Plough Reports Financial Results for 2009 Second Quarter 26Schering-Plough Reports Financial Results for 2009 Second Quarter 27
(Date:9/16/2014)... , Sept. 16, 2014  Cross Match Technologies, ... solutions, announced today the launch of its Verifier ... the identity of an individual using their secure ... Sentry rapidly reads credential documents with embedded biometric ... matching the biometric to a live scan of ...
(Date:9/15/2014)... so-called central dogma of molecular biologythat DNA makes ... explanation for how genetic information is deciphered and ... of course, the process is vastly more complicated ... ago by Nobel Laureate Francis Crick, co-discoverer of ... multiple types of RNA, three of whichmessenger RNA ...
(Date:9/15/2014)... research has determined that a single group of microorganisms ... B12 production in the oceans, with implications for the ... B12 is an essential molecule required by most life ... relatively small group of microorganisms because it is so ... key role in maintaining the brain and nervous systems, ...
Breaking Biology News(10 mins):Cross Match Launches New Identity Management Handheld Solution 2Scientists discover RNA modifications in some unexpected places 2Researchers discover new producer of crucial vitamin 2
... between researchers at the Salk Institute for Biological Studies ... the genome-wide DNA methylation pattern of the plant Arabidopsis ... - in one big sweep. , "In a ... findings and then some," says senior author Joseph Ecker, ...
... of the deadliest threats to public health. Every year ... is caused by the microorganism Mycobacterium tuberculosis. Roughly one ... and more bacterial strains have developed resistance to drugs. ... Biology Laboratory (EMBL) and the Max Planck Institute for ...
... Northwestern University research group has discovered that aggressive ... critical to proper embryo formation. , An ... the advanced online issue of the journal Nature ... embryonic growth factor by injecting aggressive melanoma cells ...
Cached Biology News:In a technical tour de force, Salk scientists take a global view of the epigenome 2In a technical tour de force, Salk scientists take a global view of the epigenome 3New potential drug target in tuberculosis 2Malignant melanoma cells secrete protein required for embryo formation 2
The Programmable MP-3500P-F Power Supply can be applied for any Microfluidic application....
Rabbit polyclonal to Synapsin II ( Abpromise for all tested applications). entrezGeneID: 6854 SwissProtID: Q92777...
... primers are designed for sequencing inserts cloned ... T7, or T3 RNA polymerase promoters, or ... supplied at a concentration of 0.1 µg/µl ... in DNA sequencing reactions using SequiTherm™ EXCEL™ ...
BD BioCoat Fibronectin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of human fibronectin....
Biology Products: